Literature DB >> 3995860

Guide to early diagnosis of biliary obstruction in infancy. Review of 143 cases.

G D Ferry, M L Selby, J Udall, M Finegold, B Nichols.   

Abstract

Presenting characteristics, long-term outcome, and techniques used in the diagnosis of 143 infants with suspected biliary obstruction are reviewed. Sixty-nine patients had surgically confirmed extrahepatic disease and 74 had intrahepatic disorders. A disproportionate number of infants with intrahepatic disease were boys (p = 0.013), low birthweight (p = 0.001), or had siblings with liver disease (p = 0.017). An initial total bilirubin of 20 mg/dl or greater was rare except in the intrahepatic disease category of neonatal hepatitis of known cause (p = 0.006). The initial percutaneous liver biopsy correctly predicted the ultimate diagnosis in 94 percent of all 143 patients. A methodological outline to diagnosis is presented, emphasizing early recognition of symptoms and careful follow-up with hepatobiliary imaging, liver biopsy, and surgical exploration, if required, until definitive diagnosis is made. This approach has aided us in reducing the age of diagnosis of biliary atresia from 12.8 +/- SD 7.3 weeks during the period 1971 through 1979 to 6.8 +/- SD 2.6 weeks from 1980 to 1982 (p = 0.0015). Eighteen-month survival has improved from 25 to 60 percent.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3995860     DOI: 10.1177/000992288502400601

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  7 in total

1.  Design and validation of the biliary atresia research consortium histologic assessment system for cholestasis in infancy.

Authors:  Pierre Russo; John C Magee; John Boitnott; Kevin E Bove; Trivellore Raghunathan; Milton Finegold; Joel Haas; Ronald Jaffe; Grace E Kim; Margret Magid; Hector Melin-Aldana; Frances White; Peter F Whitington; Ronald J Sokol
Journal:  Clin Gastroenterol Hepatol       Date:  2011-01-14       Impact factor: 11.382

2.  Key Histopathologic Features of Liver Biopsies That Distinguish Biliary Atresia From Other Causes of Infantile Cholestasis and Their Correlation With Outcome: A Multicenter Study.

Authors:  Pierre Russo; John C Magee; Robert A Anders; Kevin E Bove; Catherine Chung; Oscar W Cummings; Milton J Finegold; Laura S Finn; Grace E Kim; Mark A Lovell; Margret S Magid; Hector Melin-Aldana; Sarangarajan Ranganathan; Bahig M Shehata; Larry L Wang; Frances V White; Zhen Chen; Catherine Spino
Journal:  Am J Surg Pathol       Date:  2016-12       Impact factor: 6.394

Review 3.  Role of Hepatobiliary Scintigraphy and Preoperative Liver Biopsy for Exclusion of Biliary Atresia in Neonatal Cholestasis Syndrome.

Authors:  Ankur Mandelia; Richa Lal; Nijagal Mutt
Journal:  Indian J Pediatr       Date:  2017-07-08       Impact factor: 1.967

4.  Usefulness of a scoring system in the interpretation of histology in neonatal cholestasis.

Authors:  Way Seah Lee; Lai Meng Looi
Journal:  World J Gastroenterol       Date:  2009-11-14       Impact factor: 5.742

5.  Gene expression signature for biliary atresia and a role for interleukin-8 in pathogenesis of experimental disease.

Authors:  Kazuhiko Bessho; Reena Mourya; Pranavkumar Shivakumar; Stephanie Walters; John C Magee; Marepalli Rao; Anil G Jegga; Jorge A Bezerra
Journal:  Hepatology       Date:  2014-05-27       Impact factor: 17.425

Review 6.  Accuracy of hepatobiliary scintigraphy for differentiation of neonatal hepatitis from biliary atresia: systematic review and meta-analysis of the literature.

Authors:  Hamid Reza Kianifar; Shahrzad Tehranian; Pardis Shojaei; Zohreh Adinehpoor; Ramin Sadeghi; Vahid Reza Dabbagh Kakhki; Alireza S Keshtgar
Journal:  Pediatr Radiol       Date:  2013-03-22

7.  Initial assessment of the infant with neonatal cholestasis-Is this biliary atresia?

Authors:  Benjamin L Shneider; Jeff Moore; Nanda Kerkar; John C Magee; Wen Ye; Saul J Karpen; Binita M Kamath; Jean P Molleston; Jorge A Bezerra; Karen F Murray; Kathleen M Loomes; Peter F Whitington; Philip Rosenthal; Robert H Squires; Stephen L Guthery; Ronen Arnon; Kathleen B Schwarz; Yumirle P Turmelle; Averell H Sherker; Ronald J Sokol
Journal:  PLoS One       Date:  2017-05-11       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.